Viewing Study NCT06082934


Ignite Creation Date: 2025-12-25 @ 2:18 AM
Ignite Modification Date: 2025-12-27 @ 4:28 AM
Study NCT ID: NCT06082934
Status: RECRUITING
Last Update Posted: 2023-10-13
First Post: 2023-10-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Olverembatinib Plus Venetoclax and Dexamethasone for Treatment-naïve Ph+ Acute Lymphoblastic Leukemia
Sponsor: Xijing Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module